Skip to content
★ Sign in to follow
Shanghai HeartCare Medical Technology Corp. Ltd. - B - H Shs logo

Shanghai HeartCare Medical Technology Corp. Ltd. - B - H Shs Stock: price and insider trades · Hong Kong

HK·Mcap HK$2.1BHealth Care

Shanghai HeartCare Medical Technology Corp. Ltd. - B - H Shs: what insiders have been doing

This page follows insider dealings at Shanghai HeartCare Medical Technology Corp. Ltd. - B - H Shs as filed with HKEX, a company from the Health Care sector. From 24 October 2025 to 24 October 2026, the disclosure feed for Shanghai HeartCare Medical Technology Corp. Ltd. - B - H Shs logged 3 filings by 2 insiders.

All open-market trades in the period are sales: 2 sales worth €323k, by 1 insider, with no purchase on record. The largest single trade was a sale of €209k by Ding Kui, published on 19 May 2026.

Between a trade and the moment it shows up on HKEX, the median delay is 6 days. That lag is the time during which only the insider knows about the trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification.

For context, the typical company on the same exchange (median of 1,315 companies) published 4 filings over the same period, against 3 filings here. The full history, which starts in 2026, counts no purchases against 2 sales.

For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and EssilorLuxottica. These figures are compiled from regulatory filings published by HKEX. They describe what insiders did and are not a recommendation.

Insider Decl.
3
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€322,724
2 ops. · all time

Who traded when

BuySale
Ding Kui2 sales

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 6,392 of 26,913 companies
64.9
score / 100
Value
52
Quality
78
FCF yld6.9%
Earn yld4.1%
EV/EBITDA17.6x
ROE8.0%
Gross mgn71%
Net mgn20%
Debt/EBITDA0.4x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

HK$53.25
Analyst consensus
·
Income statement
RevenueHK$408.3M
Gross profitHK$289.5M71% margin
EBITDAHK$116.8M29% margin
Net incomeHK$83.3M18.1% margin
Valuation
PER (trailing)19.2x
P/Book1.4x
Beta0.58
Balance sheet & cash
Market capHK$2.1B
Total debtHK$42.7M
Free Cash FlowHK$140M
Debt / Equity3%
Profitability & ownership
ROE8.0%
ROA4.3%
% insiders31.9%
% institutions23.2%
Last declaration on 3 July 2026
Declarations3 total
  • ●
    DirectorExecutives
    0HKEX
    72,000 sharesShareXHKGHKEX:DA20260703E00158
  • ▼
    DirectorExecutives
    1M HKD15HKEX
    20,000 shares@ HK$52.1035.1% of flowShareXHKGHKEX:DA20260518E00421
  • ▼
    DirectorExecutives
    2M HKD17HKEX
    38,000 shares@ HK$50.526364.9% of flowShareXHKGHKEX:DA20260518E00422

3 of 3 declarations

About Shanghai HeartCare Medical Technology Corp. Ltd. - B - H Shs

Shanghai HeartCare Medical Technology Corp. Ltd. is a company focused on developing medical technologies for the treatment of heart diseases. It emphasizes innovation and improvement in cardiac healthcare.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations